![Margaret Dugan](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Margaret Dugan
Hoofd Techniek/Wetenschap/O&O bij
WHITEHAWK THERAPEUTICS, INC.
Vermogen: 6 M $ op 31-08-2026
Profiel
Margaret Han Dugan is currently an Independent Non-Executive Director at BeOne Medicines Ltd. since 2022 and will be Chief Medical Officer at Whitehawk Therapeutics, Inc. starting in 2025.
Former positions include Chief Medical Officer at Dracen Pharmaceuticals, Inc. from 2018 to 2023, Chief Medical Officer at Schrödinger, Inc., Senior VP & Head-Global Program Oncology at Novartis Pharmaceuticals Corp., Director-Oncology Clinical Research at Schering-Plough Corp., and Deputy Director-Clinical Research Oncology at Wyeth Holdings LLC.
Education includes undergraduate and doctorate degrees from New York University, conferred in 1977 and 1981 respectively.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
BEONE MEDICINES LTD. 0,01% | 11-06-2026 | 195.286 ( 0,01% ) | 5 M $ | 31-08-2026 |
SCHRODINGER, INC. 0,04% | 16-10-2025 | 24.574 ( 0,04% ) | 479 193 $ | 31-08-2026 |
| 14-05-2026 | 19.132 ( 0,04% ) | 86 859 $ | 31-08-2026 |
Actieve functies van Margaret Dugan
| Bedrijven | Functie | Begin |
|---|---|---|
| BEIGENE LTD | Directeur/Bestuurslid | 01-02-2022 |
| WHITEHAWK THERAPEUTICS, INC. | Hoofd Techniek/Wetenschap/O&O | 01-12-2025 |
Eerdere bekende functies van Margaret Dugan
| Bedrijven | Functie | Einde |
|---|---|---|
Dracen Pharmaceuticals, Inc.
 Dracen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceutical products | Hoofd Techniek/Wetenschap/O&O | 01-02-2023 |
| SCHRÖDINGER, INC. | Hoofd Techniek/Wetenschap/O&O | - |
Schering-Plough Corp.
 Schering-Plough Corp. Pharmaceuticals: MajorHealth Technology Manufactures and sells pharmaceutical & health care products | Corporate Officer/Principal | - |
Wyeth Holdings LLC
 Wyeth Holdings LLC Chemicals: AgriculturalProcess Industries Manufactures and distributes chemicals | Corporate Officer/Principal | - |
Novartis Pharmaceuticals Corp.
 Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Manufactures medicines and provides healthcare solutions | Corporate Officer/Principal | - |
Opleiding van Margaret Dugan
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
99
Eerstegraads connecties
8
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 8 |
|---|---|
Wyeth Holdings LLC
Wyeth Holdings LLC Chemicals: AgriculturalProcess Industries Manufactures and distributes chemicals | Process Industries |
Schering-Plough Corp.
Schering-Plough Corp. Pharmaceuticals: MajorHealth Technology Manufactures and sells pharmaceutical & health care products | Health Technology |
New York University
 New York University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Novartis Pharmaceuticals Corp.
Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Manufactures medicines and provides healthcare solutions | Health Technology |
Schrödinger, Inc.
 Schrödinger, Inc. Packaged SoftwareTechnology Services Develops physics-based software platform which enables discovery of novel molecules for drug development and materials applications | Technology Services |
BeiGene Ltd.
 BeiGene Ltd. Pharmaceuticals: MajorHealth Technology Develops biopharmaceutical products | Health Technology |
Dracen Pharmaceuticals, Inc.
Dracen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceutical products | Health Technology |
Aadi Bioscience, Inc.
 Aadi Bioscience, Inc. BiotechnologyHealth Technology Develops mTOR inhibitor for targeted patient populations in oncology and cardiovascular diseases | Health Technology |
